Workflow
Polyrocks(688669)
icon
Search documents
聚石化学(688669) - 天风证券股份有限公司关于广东聚石化学股份有限公司2024年度募集资金存放与实际使用情况的核查意见
2025-04-28 17:06
关于广东聚石化学股份有限公司 2024 年度募集资金存放与实际使用情况的核查意见 天风证券股份有限公司(以下简称"天风证券"、"保荐机构")作为广东聚石 化学股份有限公司(以下简称"聚石化学"、"公司")拟向特定对象发行 A 股股票 的保荐机构,根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板 股票上市规则》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的 监管要求》等相关规定,对聚石化学 2024 年度募集资金存放与实际使用情况进 行了审慎核查,具体情况如下: 天风证券股份有限公司 一、募集资金基本情况 (一)实际募集金额及资金到位情况 根据中国证券监督管理委员会(以下简称"中国证监会")出具的《关于同意 广东聚石化学股份有限公司首次公开发行股票注册的批复》(证监许可〔2020〕 3569 号),公司获准向社会公开发行人民币普通股 2,333.3334 万股,每股面值人 民币 1.00 元,每股发行价为人民币 36.65 元,合计募集资金人民币 85,516.67 万 元,扣除发行费用人民币 7,943.70 万元(不含增值税),募集资金净额为人民币 77,572.97 万元。本次募集 ...
聚石化学(688669) - 北京大成(深圳)律师事务所 关于广东聚石化学股份有限公司2025年股票期权激励计划首次授予事项之法律意见书
2025-04-28 17:06
北京大成(深圳) 律师事务所 关于 大成DENTONS 大成 is Dentons' Preferred Law Firm in China. 北京大成(深圳) 律师事务所 www.dentons.cn 广东省深圳市福田区深南大道 1006号深圳国际创新中心 A座 3、4、12层 3/F, 4/F, 12/F, Block A, Shenzhen International Innovation Center, No.1006, Shennan Boulevard, Futian District,Shenzhen 518026, P. R. China Tel: +86 755-2622 4888/4999 Fax: +86 755-2622 4111/4200 二〇二五年四月 北京大成(深圳)律师事务所 广东聚石化学股份有限公司 2025年股票期权激励计划首次授予事项 之 法律意见书 关于广东赛石化学股份有限公司 2025年股票期权激励计划首次授予事项之 法律意见书 致: 广东秦石化学股份有限公司 本所接受广东聚石化学股份有限公司(以下简称"公司"、"上市公司"或"聚石 化学") 的委托. 担任公司 20 ...
聚石化学(688669) - 广东聚石化学股份有限公司最近三年非经常性损益审核报告书
2025-04-28 17:06
广东聚石化学股份有限公司 最近三年 非经常性损益审核报告书 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址:北京市丰台区丽泽路 20 号丽泽 SOHO B座 20 层 邮编:100073 电话:(010) 51423818 传真:(010) 51423816 目 录 一、审核报告 1. 非经常性损益明细表 中 兴 华 会 计 师 事 务 所 ( 特 殊 普 通 合 伙 ) Z H O N G X I N G H U A C E R T I F I E D P U B L I C A C C O U N T A N T S L L P 地址( l o c a t i o n ): 北 京 市 丰 台 区 丽 泽 路 2 0 号丽泽 S O H O B 座 2 0 层 20/F,Tower B,Lize SOHO,20 Lize Road,Fengtai District,Beijing PR China 电话( tel ): 010 - 51423818 传真( f a x ): 010 - 5 1 4 2 3 8 1 6 关 ...
聚石化学(688669) - 关于广东冠臻科技有限公司2024年度业绩承诺完成情况的鉴证报告
2025-04-28 17:06
关于广东冠臻科技有限公司 2024年度业绩承诺完成情况的 鉴证报告 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址:北京市丰台区丽泽路 20 号丽泽 SOHO B 座 20 层 邮编:100073 电话:010-51423818 传真:010-51423816 目 录 中兴华核字(2025)第 410012 号 1.中兴华会计师事务所(特殊普通合伙)营业执照复印件 2.中兴华会计师事务所(特殊普通合伙)执业证书复印件 3.注册会计师执业证书复印件 一、业绩承诺完成情况的鉴证报告 二、业绩承诺完成情况的说明 三、审计报告附件 中兴华会计师事务所(特殊普通合伙) 中 兴 华 会 计 师 事 务 所 ( 特 殊 普 通 合 伙 ) Z H O N G X I N G H U A C E R T I F I E D P U B L I C A C C O U N T A N T S L L P 地址( l o c a t i o n ) : 北 京 市 丰 台 区 丽 泽 路 2 0 号 丽 泽 S O H O B 座 2 0 层 ...
聚石化学(688669) - 2024年度审计报告
2025-04-28 17:06
广东聚石化学股份有限公司 2024年度合并及母公司财务报表 审计报告书 中兴华会计师事务所(特殊普通合伙) ZHONGXINGHUA CERTIFIED PUBLIC ACCOUNTANTS LLP 地址:北京市丰台区丽泽路 20 号丽泽 SOHO B座 20 层 邮编:100073 电话:(010) 51423818 传真:(010) 51423816 目 录 | 一、审计报告 | 1 | | --- | --- | | 二、审计报告附送 | | | 1. 合并及母公司资产负债表 | 5 | | 2. 合并及母公司利润表 | 9 | | 3. 合并及母公司现金流量表 | 11 | | 4. 合并股东权益变动表 | 13 | | 5. 母公司股东权益变动表 | 15 | | 6. 财务报表附注 | 17 | | 三、审计报告附件 | | 1. 中兴华会计师事务所(特殊普通合伙)营业执照复印件 2. 中兴华会计师事务所(特殊普通合伙)执业证书复印件 3. 注册会计师执业证书复印件 中兴华会计师事务所(特殊普通合伙) 中 兴 华 会 计 师 事 务 所 ( 特 殊 普 通 合 伙 ) Z H O N G X I ...
聚石化学(688669) - 2024年度独立董事述职报告(陈桂林)
2025-04-28 16:38
广东聚石化学股份有限公司 广东聚石化学股份有限公司 2024 年度独立董事述职报告 2024 年度独立董事述职报告 本人陈桂林作为广东聚石化学股份有限公司(以下简称"公司")独立董事, 在 2024 年度(以下简称"报告期")严格按照《中华人民共和国公司法》《上 市公司独立董事管理办法》《上市公司治理准则》等法律法规、规范性文件以及 《广东聚石化学股份有限公司章程》(以下简称《公司章程》)、《广东聚石化 学股份有限公司独立董事工作制度》(以下简称《独立董事工作制度》)、《广 东聚石化学股份有限公司独立董事专门会议工作细则》《广东聚石化学股份有限 公司董事会审计委员会工作细则》(以下简称《审计委员会工作细则》)、《广 东聚石化学股份有限公司董事会薪酬与考核委员会工作细则》(以下简称《薪酬 与考核委员会工作细则》)的规定和要求,认真、勤勉、独立地履行职责,积极 出席相关会议,认真审议董事会各项议案,充分发挥了独立董事及各专门委员会 委员的作用,切实维护了公司和全体股东的利益。现将本人报告期内履行独立董 事职责情况汇报如下: 一、独立董事的基本情况 (一)现任独立董事个人情况 本人陈桂林,1961 年出生,中国国籍 ...
聚石化学(688669) - 2024年度独立董事述职报告(曾幸荣)
2025-04-28 16:38
广东聚石化学股份有限公司 2024 年度独立董事述职报告 广东聚石化学股份有限公司 2024 年度独立董事述职报告 本人曾幸荣作为广东聚石化学股份有限公司(以下简称"公司")独立董事, 在 2024 年度(以下简称"报告期")严格按照《中华人民共和国公司法》《上 市公司独立董事管理办法》《上市公司治理准则》等法律法规、规范性文件以及 《广东聚石化学股份有限公司章程》(以下简称《公司章程》)、《广东聚石化 学股份有限公司独立董事工作制度》(以下简称《独立董事工作制度》)、《广 东聚石化学股份有限公司董事会提名委员会工作细则》(以下简称《提名委员会 工作细则》)、《广东聚石化学股份有限公司董事会战略委员会工作细则》(以 下简称《战略委员会工作细则》)的规定和要求,认真、勤勉、独立地履行职责, 积极出席相关会议,认真审议董事会各项议案,充分发挥了独立董事及各专门委 员会委员的作用,切实维护了公司和全体股东的利益。现将本人报告期内履行独 立董事职责情况汇报如下: 一、独立董事的基本情况 (一)现任独立董事个人情况 本人曾幸荣,1962 年生,中国国籍,无境外永久居留权,1989 年 12 月毕业 于华南理工大学高分子 ...
聚石化学(688669) - 2024年度独立董事述职报告(孟跃中)
2025-04-28 16:38
广东聚石化学股份有限公司 2024 年度独立董事述职报告 广东聚石化学股份有限公司 2024 年度独立董事述职报告 本人孟跃中作为广东聚石化学股份有限公司(以下简称"公司")独立董事, 在 2024 年度(以下简称"报告期")严格按照《中华人民共和国公司法》《上 市公司独立董事管理办法》《上市公司治理准则》等法律法规、规范性文件以及 《广东聚石化学股份有限公司章程》(以下简称《公司章程》)、《广东聚石化 学股份有限公司独立董事工作制度》(以下简称《独立董事工作制度》)、《广 东聚石化学股份有限公司独立董事专门会议工作细则》《广东聚石化学股份有限 公司董事会提名委员会工作细则》(以下简称《提名委员会工作细则》)、《广 东聚石化学股份有限公司董事会薪酬与考核委员会工作细则》(以下简称《薪酬 与考核委员会工作细则》)、《广东聚石化学股份有限公司董事会审计委员会工 作细则》(以下简称《审计委员会工作细则》)的规定和要求,认真、勤勉、独 立地履行职责,积极出席相关会议,认真审议董事会各项议案,充分发挥了独立 董事及各专门委员会委员的作用,切实维护了公司和全体股东的利益。现将本人 报告期内履行独立董事职责情况汇报如下: ...
聚石化学(688669) - 2024 Q4 - 年度业绩预告
2025-04-28 16:25
Financial Performance - The total operating revenue for the reporting period was revised to CNY 4,080,206,398.29, representing a year-on-year increase of 10.72% from CNY 3,685,171,155.32[2] - The operating profit was revised to a loss of CNY 240,904,591.23, a decrease of 849.27% compared to the previous year's profit of CNY 32,151,808.82[2] - The total profit was revised to a loss of CNY 242,051,321.30, reflecting a decrease of 748.52% from the previous year's profit of CNY 37,323,486.55[2] - The net profit attributable to the parent company was revised to a loss of CNY 143,463,646.44, a decrease of 926.31% compared to the previous year's profit of CNY 28,578,460.37[2] - The basic earnings per share were revised to CNY -1.95, a decrease of 910.94% from the previous year's earnings of CNY 0.24[3] Assets and Liabilities - The total assets at the end of the reporting period were CNY 5,223,812,117.69, an increase of 4.39% from CNY 4,894,402,986.96 in the same period last year[3] - The net assets attributable to the parent company decreased by 16.80% to CNY 1,398,895,697.80 from CNY 1,567,684,666.38 in the previous year[3] Impairment Losses - The company recognized impairment losses totaling CNY 4,362 million related to the acquisition of Guangdong Guanzhen Technology Co., Ltd. due to underperformance[6] - The company also recorded impairment losses of CNY 2,175 million on fixed assets related to its leasing business[6] Future Commitments - The company expressed its commitment to improve the accuracy of future financial reporting and enhance communication with auditors[7]
聚石化学(688669) - 2024 Q4 - 年度财报
2025-04-28 16:25
Financial Performance - The company's operating revenue for 2024 reached ¥4,080,206,398.29, an increase of 10.72% compared to ¥3,685,171,155.3 in 2023[22]. - The net profit attributable to shareholders decreased by 926.31% to -¥236,146,837.06 from ¥28,578,460.37 in the previous year[24]. - The net cash flow from operating activities increased by 64.08% to ¥403,926,506.56, up from ¥246,169,798.09 in 2023[22]. - The total assets rose to ¥5,109,031,810.26, a 4.39% increase from ¥4,894,402,986.9 in 2023[22]. - Basic earnings per share fell to -¥1.95 from ¥0.24 in 2023, a decrease of 912.5%[23]. - The company reported a research and development expense ratio of 3.40% of operating revenue, slightly down from 3.49% in 2023[23]. - The company recorded a net profit attributable to shareholders of -¥226,756,499.25 in the fourth quarter of 2024[26]. - The company achieved operating revenue of CNY 4,080.21 million, a year-on-year increase of 10.72%, with main business revenue of CNY 4,047.01 million, up 10.38% year-on-year[33]. - The net profit attributable to shareholders was CNY -236.15 million, a significant decline of 926.31% year-on-year, while the net profit excluding non-recurring gains and losses was CNY -206.08 million[33]. Risk Management - The company is facing various operational risks, which are detailed in the management discussion and analysis section[4]. - The company has a comprehensive risk statement regarding forward-looking statements, advising investors to be cautious[7]. - The company has not reported any non-operational fund occupation by controlling shareholders or related parties[8]. - The company has not experienced any violations of decision-making procedures regarding external guarantees[8]. - The company has not reported any instances where more than half of the directors could not guarantee the accuracy of the annual report[9]. - The company faces risks related to significant profit declines and potential core technology infringement, which could impact its competitive advantage[80]. Governance and Compliance - The company has confirmed that all board members attended the board meeting, ensuring governance compliance[5]. - The company has established a comprehensive quality management system, adhering to ISO9001:2015 and IATF16949:2016 standards, ensuring product quality across all processes[75]. - The company maintains independence from its controlling shareholder, ensuring no interference in decision-making or operations[152]. - Investor relations are prioritized, with multiple channels for communication and feedback from stakeholders[152]. - The company adheres to strict information disclosure practices, ensuring transparency and equal access to information for all shareholders[153]. - The company held multiple shareholder meetings in 2024, with all proposed resolutions passing without any objections[154]. - The company held a total of 6 board meetings during the year, with 5 conducted in a combined format of on-site and communication[175]. - The supervisory board also held 6 meetings, actively monitoring the management of raised funds and the execution of board resolutions[151]. Research and Development - The company is focusing on expanding its overseas market while enhancing R&D investment to drive high-quality development[33]. - The company has established strategic partnerships with numerous well-known domestic and international enterprises to enhance competitiveness and risk resistance[40]. - The company added 27 authorized invention patents and 23 utility model patents in the reporting period, reflecting its commitment to innovation[38]. - The company is actively involved in the development of new materials, including LCD photoresists and biodegradable materials, through collaborations with various research institutions and universities[41]. - The company’s product "Flame Retardant Polypropylene" was awarded the title of "National Manufacturing Single Champion Product"[38]. - R&D expenses amounted to 138.83 million yuan, an increase of 7.89% year-over-year, representing 3.40% of total revenue[37]. - The company has filed 86 new intellectual property applications during the reporting period, including 70 invention patents, and received 50 new authorizations, with a total of 433 authorized intellectual property projects to date[61]. - The company is focusing on the development of new materials such as LCD photoresists and biodegradable materials, aiming to strengthen its market position[72]. Market Expansion and Strategy - The company is in the process of expanding its market presence and developing new products, although specific details are not provided in the available content[3]. - The company is focusing on sustainable development, responding to increasing market demand for environmentally friendly and recyclable modified plastics[53]. - The company is actively pursuing industrialization of its new products and technologies, with ongoing application validation for its flame retardant products[68]. - The company is expanding its market presence by integrating industry-related R&D platforms and promoting collaborative development across the industry chain[123]. - The company is considering strategic acquisitions to enhance its product portfolio and market presence[162]. - The company plans to expand the production of optical display materials, particularly increasing the output of light guide plates[147]. - The company is expanding its upstream and downstream operations through research成果转化 and acquisitions, aiming to enhance supply chain control and product performance[74]. Employee and Management - The company has established a training program that includes systematic onboarding and ongoing training for employees, focusing on skill development and management training[184]. - The company has a total of 2,172 employees, with 500 in the parent company and 1,672 in major subsidiaries[182]. - The total compensation for R&D personnel increased to 5,449.57 million RMB, with an average salary of 15.98 million RMB[71]. - The company continues to focus on employee motivation through equity incentives to enhance performance and retention[192]. - The average age of key personnel in core technology roles is 45 years, indicating a mature workforce with extensive experience[161]. Production and Operations - The company is currently in the construction or expansion phase for several new businesses, impacting overall profitability and increasing costs[24]. - The company achieved a production capacity of 160,000 tons of isooctane annually, enhancing product competitiveness for use in national VI gasoline blending components[58]. - The company has a production capacity of 81,000 tons for modified plastic particles with a utilization rate of 84.69%[134]. - The company is currently constructing a 10,000-ton capacity for phosphorus pentoxide, with an investment of 2,344.76 million RMB expected to be completed by August 2025[134]. - The company has improved production efficiency by over 30% through a one-step method for synthesizing triazine organic compounds, replacing the traditional multi-step process[55]. Financial Management - The company's cash flow from financing activities decreased by 92.76% year-on-year to 23.40 million RMB, mainly due to increased repayments[112]. - The company's cash and cash equivalents at the end of the period were 151.82 million RMB, down 27.81% from the previous period[114]. - The accounts receivable decreased by 15.62% year-on-year to 2,424.89 million RMB, indicating improved collection efficiency[114]. - The company reported a significant reduction in production costs by 8% due to improved supply chain management[167]. - The company has a total of 1,092,294,487.92 RMB in restricted assets, including cash and fixed assets[119].